American Journal of Obstetrics & Gynecology
Volume 197, Issue 3, Supplement , Pages S96-S100 , September 2007

Cesarean delivery for HIV-infected women: recommendations and controversies

  • Denise J. Jamieson, MD, MPH

      Affiliations

    • Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA
    • Corresponding Author InformationReprints: Denise J. Jamieson, MD, MPH, Centers for Disease Control and Prevention, 4770 Buford Hwy, Mallstop K-34, Atlanta, Georgia 30333.
    • ,
  • Jennifer S. Read, MD, MPH

      Affiliations

    • Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD
    • ,
  • Athena P. Kourtis, MD, PhD, MPH

      Affiliations

    • Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • Tonji M. Durant, PhD

      Affiliations

    • Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (proposed), Centers for Disease Control and Prevention, Atlanta, GA.
    • ,
  • Margaret A. Lampe, RN, MPH

      Affiliations

    • Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (proposed), Centers for Disease Control and Prevention, Atlanta, GA.
    • ,
  • Kenneth L. Dominguez, MD, MPH

      Affiliations

    • Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (proposed), Centers for Disease Control and Prevention, Atlanta, GA.

Received 15 December 2006 ,Accepted 26 February 2007.

References 

  1. Hamilton BE, Martin JA, Ventura SJ, Sutton PD, Menacker F. Births: preliminary data for 2004. Natl Vital Stat Rep. 2005;54:1–17
  2. Meikle SF, Steiner CA, Zhang J, Lawrence WL. A national estimate of the elective primary cesarean delivery rate. Obstet Gynecol. 2005;105:751–756
  3. Ryan K, Schnatz P, Greene J, Curry S. Change in cesarean section rate as a reflection of the present malpractice crisis. Conn Med. 2005;69:139–141
  4. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: final data for 2003. Natl Vital Stat Rep. 2005;54:1–116
  5. Dominguez KL, Lindegren ML, D’Almada PJ, et al. Increasing trend of cesarean deliveries in HIV-infected women in the United States from 1994 to 2000. J Acquir Immune Defic Syndr. 2003;33:232–238
  6. Duliege AM, Amos CI, Felton S, Biggar RJ, Goedert JJ. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins: International Registry of HIV-Exposed Twins. J Pediatr. 1995;126:625–632
  7. Goedert JJ, Duliege AM, Amos CI, Felton S, Biggar RJ. High risk of HIV-1 infection for first-born twins: the International Registry of HIV-exposed Twins. Lancet. 1991;338:1471–1475
  8. Italian Multicentre Study. Epidemiology, clinical features, and prognostic factors of paediatric HIV infection. Lancet. 1988;2:1043–1046
  9. Kind C, Rudin C, Siegrist CA, et al. Prevention of vertical HIV transmission: additive protective effect of elective cesarean section and zidovudine prophylaxis: Swiss Neonatal HIV study group. AIDS. 1998;12:205–210
  10. Kuhn L, Bobat R, Coutsoudis A, et al. Cesarean deliveries and maternal-infant HIV transmission: results from a prospective study in South Africa. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11:478–483
  11. Maguire A, Sanchez E, Fortuny C, Casabona J. Potential risk factors for vertical HIV-1 transmission in Catalonia, Spain: the protective role of cesarean section: the Working Group on HIV-1 Vertical Transmission in Catalonia. AIDS. 1997;11:1851–1857
  12. The European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet. 1994;343:1464–1467
  13. Hutto C, Parks WP, Lai SH, et al. A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1. J Pediatr. 1991;118:347–353
  14. Boyer PJ, Dillon M, Navaie M, et al. Factors predictive of maternal-fetal transmission of HIV-1: preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA. 1994;271:1925–1930
  15. Landesman SH, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child: the Women and Infants Transmission study. N Engl J Med. 1996;334:1617–1623
  16. Simonds RJ, Steketee R, Nesheim S, et al. Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV: perinatal AIDS Collaborative Transmission studies. AIDS. 1998;12:301–308
  17. Kourtis AP, Bulterys M, Nesheim SR, Lee FK. Understanding the timing of HIV transmission from mother to infant. JAMA. 2001;285:709–712
  18. International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: a meta-analysis of 15 prospective cohort studies. N Engl J Med. 1999;340:977–987
  19. Read JS, Newell MK. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. Cochrane Database Syst Rev. 2005;4:CD005479
  20. American College of Obstetricians and Gynecologists. Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection: ACOG committee opinion no.: 234 (replaces no.: 219). Int J Gynaecol Obstet. 2001;73:279–281
  21. American College of Obstetricians and Gynecologists. Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection: ACOG committee opinion no.: 219: Committee on Obstetric Practice. Int J Gynaecol Obstet. 1999;66:305–306
  22. Semprini AE. An international randomized trial of mode of delivery in HIV infected women. In: Conference Supplement for 12th World AIDS Conference, June 1998, Geneva, Switzerland. 2006.
  23. Read J. Mode of delivery and vertical transmission of HIV-1: a meta-analysis from fifteen prospective cohort studies [abstract]. In: Conference Supplement for 12th World AIDS Conference, June 1998, Geneva, Switzerland. 2006.
  24. European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet. 1999;353:1035–1039
  25. Centers for Disease Control and Prevention. US Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR Recomm Rep. 2002;51:1–38
  26. Naver L, Lindgren S, Belfrage E, et al. Children born to HIV-1-infected women in Sweden in 1982-2003: trends in epidemiology and vertical transmission. J Acquir Immune Defic Syndr. 2006;42:484–489
  27. Coll O, Fiore S, Floridia M, et al. Pregnancy and HIV infection: a European consensus on management. AIDS. 2002;16(suppl):S1–S18
  28. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458–465
  29. Grubert TA, Reindell D, Kastner R, Lutz-Friedrich R, Belohradsky BH, Dathe O. Complications after caesarean section in HIV-1-infected women not taking antiretroviral treatment. Lancet. 1999;354:1612–1613
  30. Maiques-Montesinos V, Cervera-Sanchez J, Bellver-Pradas J, bad-Carrascosa A, Serra-Serra V. Post-cesarean section morbidity in HIV-positive women. Acta Obstet Gynecol Scand. 1999;78:789–792
  31. Rodriguez EJ, Spann C, Jamieson D, Lindsay M. Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women. Am J Obstet Gynecol. 2001;184:1108–1111
  32. Semprini AE, Castagna C, Ravizza M, et al. The incidence of complications after caesarean section in 156 HIV-positive women. AIDS. 1995;9:913–917
  33. Urbani G, de Vries MM, Cronje HS, Niemand I, Bam RH, Beyer E. Complications associated with cesarean section in HIV-infected patients. Int J Gynaecol Obstet. 2001;74:9–15
  34. Vimercati A, Greco P, Loverro G, Lopalco PL, Pansini V, Selvaggi L. Maternal complications after caesarean section in HIV infected women. Eur J Obstet Gynecol Reprod Biol. 2000;90:73–76
  35. Faucher P, Batallan A, Bastian H, et al. Management of pregnant women infected with HIV at Bichat Hospital between 1990 and 1998: analysis of 202 pregnancies. Gynecol Obstet Fertil. 2001;29:211–225
  36. Fiore S, Newell ML, Thorne C. Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery. AIDS. 2004;18:933–938
  37. Marcollet A, Goffinet F, Firtion G, et al. Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery. Am J Obstet Gynecol. 2002;186:784–789
  38. Read JS, Tuomala R, Kpamegan E, et al. Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study. J Acquir Immune Defic Syndr. 2001;26:236–245
  39. Watts DH, Lambert JS, Stiehm ER, et al. Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of ≤500/μL. Am J Obstet Gynecol. 2000;183:100–107
  40. American College of Obstetricians and Gynecologists. Prophylactic antibiotics in labor and delivery: ACOG practice bulletin no.: 47. Obstet Gynecol. 2003;102:875–882
  41. Navas-Nacher EL, Read JS, Leighty RM, et al. Mode of delivery and postpartum HIV-1 disease progression: the Women and Infants Transmission study. AIDS. 2006;20:429–436
  42. Bjorklund K, Mutyaba T, Nabunya E, Mirembe F. Incidence of postcesarean infections in relation to HIV status in a setting with limited resources. Acta Obstet Gynecol Scand. 2005;84:967–971
  43. Bulterys M, Chao A, Dushimimana A, Saah A. Fatal complications after cesarean section in HIV-infected women. AIDS. 1996;10:923–924
  44. Miller JM. Maternal and neonatal morbidity and mortality in cesarean section. Obstet Gynecol Clin North Am. 1988;15:629–638
  45. Halpern MT, Read JS, Ganoczy DA, Harris DR. Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1. AIDS. 2000;14:691–700
  46. Mrus JM, Goldie SJ, Weinstein MC, Tsevat J. The cost-effectiveness of elective cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy. AIDS. 2000;14:2543–2552
  47. Ratcliffe J, Ades AE, Gibb D, Sculpher MJ, Briggs AH. Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness. AIDS. 1998;12:1381–1388
  48. Chen KT, Sell RL, Tuomala RE. Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus-infected women. Obstet Gynecol. 2001;97:161–168
  49. Bulterys M, Nolan M, Jamieson DJ, Dominguez K, Fowler MG. Advances in the prevention of mother-to-child HIV-1 transmission: current issues, future challenges. AIDS Science. 2002;2(4):
  50. Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission: Women and Infants Transmission study group. N Engl J Med. 1999;341:394–402
  51. Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Last accessed: August 22, 2006. Available at: http://AIDSinfo.nih.gov.
  52. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29:484–494
  53. Dorenbaum A, Cunningham CK, Gelber RD, et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA. 2002;288:189–198
  54. Ioannidis JP, Abrams EJ, Ammann A, et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/mL. J Infect Dis. 2001;183:539–545
  55. International Perinatal HIV Group. Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies. AIDS. 2001;15:357–368

 The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the Department of Health and Human Services.

PII: S0002-9378(07)00270-0

doi: 10.1016/j.ajog.2007.02.034

American Journal of Obstetrics & Gynecology
Volume 197, Issue 3, Supplement , Pages S96-S100 , September 2007

Article Tools